Towa Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	1,162	815	876	646	1,006	926
Market Cap Growth	24.50%	-6.98%	35.63%	-35.82%	8.64%	-1.83%
Enterprise Value	2,224	2,015	1,890	1,544	1,447	1,443
Last Close Price	23.40	15.98	17.13	12.26	18.34	-
PE Ratio	9.98	6.95	8.84	42.38	8.53	8.61
PS Ratio	0.79	0.51	0.63	0.45	0.82	0.78
PB Ratio	1.13	0.77	0.92	0.68	1.03	1.03
P/TBV Ratio	1.46	1.05	1.36	1.11	1.74	1.18
P/FCF Ratio	33.76	-	-	-	12.35	41.88
P/OCF Ratio	6.94	5.64	17.41	36.67	6.13	10.01
EV/Sales Ratio	1.50	1.26	1.35	1.07	1.18	1.21
EV/EBITDA Ratio	8.78	7.52	8.68	8.95	6.62	6.17
EV/EBIT Ratio	16.83	14.03	17.48	40.43	10.53	9.40
EV/FCF Ratio	64.61	-	-	-	17.76	65.24
Debt / Equity Ratio	1.23	1.38	1.32	1.26	1.09	0.73
Debt / EBITDA Ratio	-	5.45	5.80	6.94	4.89	2.79
Debt / FCF Ratio	36.87	-	-	-	13.12	29.53
Net Debt / Equity Ratio	1.02	1.11	1.13	1.09	0.84	0.53
Net Debt / EBITDA Ratio	4.19	4.40	4.97	5.97	3.77	2.04
Net Debt / FCF Ratio	30.58	-35.78	-5.96	-5.68	10.13	21.54
Asset Turnover	-	0.58	0.57	0.60	0.57	0.65
Inventory Turnover	-	1.58	1.51	1.64	1.43	1.61
Quick Ratio	1.30	1.33	1.26	1.00	0.73	1.33
Current Ratio	2.84	2.81	2.72	2.33	1.45	2.67
Return on Equity (ROE)	-	11.59%	11.05%	1.64%	12.79%	12.62%
Return on Assets (ROA)	-	3.22%	2.75%	0.98%	4.03%	5.26%
Return on Invested Capital (ROIC)	6.43%	4.82%	3.78%	1.00%	6.29%	8.57%
Return on Capital Employed (ROCE)	6.10%	6.10%	5.00%	1.90%	8.60%	10.30%
Earnings Yield	10.02%	14.40%	11.31%	2.36%	11.72%	11.61%
FCF Yield	2.96%	-4.04%	-20.74%	-28.07%	8.10%	2.39%
Dividend Yield	2.03%	2.71%	2.15%	3.39%	2.30%	-
Payout Ratio	-	15.55%	18.25%	140.84%	15.15%	15.52%
Buyback Yield / Dilution	-0.01%	-0.01%	0.00%	2.19%	1.86%	3.57%
Total Shareholder Return	2.02%	2.70%	2.15%	5.58%	4.16%	3.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.